|
Group Medical Director (GMD), Tumor Dependencies, Oncology Early Development Group Medical Director (GMD), Tumor Dependencies, Oncology Early Development AbbVie has a proven track record in hematologic malignancies, including several approved indications for Imbruvica and Venclexta. Building the oncology portfolio through the strategic development of a broad pipeline is a key focus for AbbVie. The tumor dependencies group in early oncology seeks to build upon our current presence in hematologic malignancies and help define the next generation of therapeutic advances to. After registering you may be able to apply for this job directly (if still active) on (AbbVie)'s site. Future job matches may be sent from Geebo approved job partners.
|